ABSTRACT: Vasomotor and vaginal symptoms are cardinal symptoms of menopause. Vasomotor symptoms can be particularly troubling to women and are the most commonly reported menopausal symptoms, with a reported prevalence of 50–82% among U.S. women who experience natural menopause 2. The occurrence of vasomotor symptoms increases during the transition to menopause and peaks approximately 1 year after the final menstrual period 3 4 5. The purpose of this document is to provide evidence-based guidelines for the treatment of vasomotor and vaginal symptoms related to natural and surgical menopause. (Treatment of menopausal symptoms in cancer survivors is discussed in the American College of Obstetricians and Gynecologists’ Practice Bulletin Number 126, Management of Gynecologic Issues in Women With Breast Cancer.)
- Jump to
- Search page
-
Resources
Resources Close
By reading this page you agree to ACOG's Terms and Conditions. Read terms
Log in to read on Obstetrics & Gynecology
This content is only available to ACOG members and subscribers of Obstetrics & Gynecology.
Log In
Nonmembers: Become an ACOG member to receive access to all of ACOG’s clinical guidance documents or subscribe to Obstetrics & Gynecology.
Current ACOG Clinical Subscribers: You can log in until August. After August, you can view the gated clinical guidance resources through the end of your subscription date using a personalized link sent to you via email.
You’ll find clinical content, written and peer-reviewed by experts, that provides trusted, evidence-based guidance on the diagnosis and management of the full spectrum of obstetric and gynecologic conditions and related clinical issues.
Note for Life Fellows: You can receive a special discounted annual subscription fee of $95 for access to clinical guidance documents on Obstetrics & Gynecology. Individual subscriptions include print and online access for U.S. subscribers and online-only access for international subscribers. Subscribe today.
Reaffirmed 2024
